All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Pr Newswire

Nectero Medical Secures Category III CPT Codes for Investigational Therapy to...

admin
Pr Newswire

Rgenta Therapeutics Presents Preclinical Data from Lead Program, RGT-61159, a Potent...

admin
Pr Newswire

DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions...

admin
Pr Newswire

DayOne Signs Landmark CRESS Agreement with TNB to Secure Up to...

admin
Pr Newswire

Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing

admin
Pr Newswire

Metalpha Announces Successful Conclusion of Next Generation Fund with Exceptional Performance

admin
Pr Newswire

Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and...

admin
Pr Newswire

HTX May Performance Report: Trading Volume Surges, Assets Grow Steadily, Rankings...

admin
People

Aspen Ideas Festival Releases Agenda for 2025, Setting the Stage for...

admin
People

Optimove Releases 2025 Consumer Summer Shopping Report: Economic Anxiety Spurs Demand...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...